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Tetramethylenedisulfotetramine
TETSTetramethylenedisulfotetramine (TETS) is a potent convulsant poison that is thought to trigger seizures by
inhibiting the function of the type A gamma-aminobutyric acid receptor (GABAAR). Acute intoxication with
TETS can cause vomiting, convulsions, status epilepticus (SE) and even death. Clinical case reports indicate that
individuals who survive poisoning may exhibit long-term neuropsychological issues and cognitive deﬁcits.
Therefore, the objective of this research was to determine whether a recently described mouse model of acute
TETS intoxication exhibits persistent behavioral deﬁcits. Young adult male NIH Swiss mice received a seizure-
inducing dose of TETS (0.15 mg/kg, ip) and then were rescued from lethality by administration of diazepam
(5 mg/kg, ip) approximately 20 min post-TETS-exposure. TETS-intoxicated mice typically exhibited 2 clonic sei-
zures prior to administration of diazepamwith no subsequent seizures post-diazepam injection as assessed using
behavioral criteria. Seizures lasted an average of 72 s. Locomotor activity, anxiety-like and depression-relevant
behaviors and cognition were assessed at 1 week, 1 month and 2 months post-TETS exposure using open
ﬁeld, elevated-plus maze, light↔ dark transitions, tail suspension, forced swim and novel object recognition
tasks. Interestingly, preliminary validation tests indicated that NIH Swiss mice do not respond to the shock in
fear conditioning tasks. Subsequent evaluation of hot plate and tail ﬂick nociception tasks revealed that this strain
exhibits signiﬁcantly decreased pain sensitivity relative to age- and sex-matched C57BL/6Jmice, which displayed
normal contextual fear conditioning. NIH Swiss mice acutely intoxicated with TETS exhibited no signiﬁcant
anxiety-related, depression-relevant, learning or memory deﬁcits relative to vehicle controls at any of the time
points assessed with the exception of signiﬁcantly increased locomotor activity at 2 months post-TETS intoxica-
tion. The general absence of long-term behavioral deﬁcits in TETS-intoxicated mice on these six assays suggests
that the neurobehavioral consequences of TETS exposure described in human survivors of acute TETS intoxica-
tion are likely due to sustained seizure activity, rather than a direct effect of the chemical itself. Future research
efforts are directed toward developing an animal model that better recapitulates the SE and seizure duration
reported in humans acutely intoxicated with TETS.
© 2014 Elsevier Inc. All rights reserved.ctroencephalography; EPM, ele-
id receptor; Ip, intraperitoneal;
line; SD, standard deviation; SE,
VEH, vehicle.
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Tetramethylenedisulfotetramine (TETS) is a GABAAR antagonist that
was widely used as a rodenticide until an international ban on its pro-
duction in 1991 (Whitlow et al., 2005). However, due to its relative
ease of synthesis and low production costs, TETS remains available on
the international black market. In 2000, the National Poison Control
Center of China revealed that 74% of commercial rodenticides in that
country contained illegal chemicals, with TETS found in nearly 50% of
these products (Banks et al., 2014). TETS is a potent chemical convul-
sant. The LD50 for TETS in rodents and rabbits is 0.1–0.2 mg/kg ip, and
7–10 mg is considered to be a lethal dose for an adult human (Croddy,
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clonic–tonic convulsions that can progress to status epilepticus (SE),
arrhythmias, coma, and death (Barrueto et al., 2003; Li et al., 2012; Lu
et al., 2008; Zhang et al., 2011). TETS has been implicated in both
accidental and intentional poisoning of as many as 14,000 individuals
in China between 1991 and 2010, as well as more than 50 human poi-
sonings in Western countries since 2002 (Li et al., 2012; Zhang et al.,
2011). More recently, in March 2014, 30 kindergarten children in the
Yunnan province of China were poisoned by a classmate and two of
those victims died (Ramzy, 2014).
Clinical case reports indicate that individuals who survive acute in-
toxication with TETS at levels that cause seizures may experience de-
layed or long-term effects, including abnormal electroencephalography
(EEG), spontaneous recurrent seizures, anxiety and/or depressive disor-
ders andmemory impairments that persist formonths to years following
exposure (Bai et al., 2005; Whitlow et al., 2005; Zhang et al., 2011).
Additionally, acute TETS poisoning may cause developmental delays in
children and adversely affect cognitive development, as evidenced by
lower verbal, performance and overall intelligence scores in children
exposed to TETS compared to controls (Bai et al., 2005; Whitlow et al.,
2005; Zhang et al., 2011).
We recently characterized amousemodel of acute TETS intoxication
(Zolkowska et al., 2012), which conﬁrmed the high potency of TETS as a
convulsant in the NIH Swiss strain. In this model, TETS triggered clonic–
tonic seizures, as assessed using both behavioral (Zolkowska et al.,
2012) and electroencephalographic (EEG) criteria (Vito et al., in
press). Another group has reported similar ﬁndings in C57BL/6J mice
and further demonstrated that administration of a high dose of diaze-
pam (5 mg/kg, ip), a GABAAR positive allosteric modulator, protected
these mice from further motor seizures and increased survival at 1 h
post-TETS exposure (Shakarjian et al., 2012). We recently extended
this observation to the NIH Swiss strain, demonstrating that when ad-
ministered approximately 20 min post-TETS, diazepam stops further
behavioral and EEG seizures (Vito et al., in press).
Histological examination of brains from animals that received suble-
thal doses of TETS (Zolkowska et al., 2012) revealed neuroinﬂammation
in the hippocampus and cortex evident as increased IBA-1 immunoreac-
tivity on days 1 and 2post-exposure and increasedGFAP immunoreactiv-
ity on days 2 and 3 post-exposure. Both GFAP and IBA-1
immunoreactivity returned to control levels by 7 d post-exposure,
whichwas the latest timepoint examined in that study. Subsequent stud-
ies of animals intoxicated with a lethal dose of TETS and then “rescued”
from death by diazepam (Vito et al., in press) found that treatment
with diazepam did not mitigate neuroinﬂammation associated with
TETS intoxication: GFAP immunoreactivity was still signiﬁcantly in-
creased at 2 and 3 d post-exposure but returned to control levels by 7 d
post-exposure; however, increased IBA-1 immunoreactivity persisted
up to 7 d post-exposure. Neuroinﬂammation has been associated with
various behavioral deﬁcits, including depression, anxiety and impaired
memory (Corona et al., 2012; Dantzer et al., 2008; Maes et al., 2009;
Smith, 2013). Collectively, these data suggest that TETS-induced neuroin-
ﬂammation may contribute to the behavioral deﬁcits and memory im-
pairments reported in humans that survive acute TETS intoxication.
Therefore, the goal of this research was to characterize the effects of
acute TETS intoxication in the NIH Swiss mouse model on cognitive and
emotional behaviors. To our knowledge, these are the ﬁrst experiments
addressing TETS-induced behavioral and cognitive deﬁcits in an animal
model.
2. Methods
2.1. Chemicals
Sulfamide, hydrochloric acid, acetone, and hexane were obtained
from Thermo Fisher Scientiﬁc (Waltham, MA). All chemicals were of
the highest purity available. TETS was synthesized as previouslydescribed (Zolkowska et al., 2012). A ﬁnal recrystallization step was
performed to ensure no water remained in the crystals and characteri-
zation of the ﬁnal product by gas chromatography–mass spectrometry
supported the assigned structure of TETS and its high purity. The prod-
uct was N98% pure based on integration of total ion current. USP grade
diazepam (in 40% propylene glycol, 10% alcohol, 5% sodium benzoate
and 1.5% benzyl alcohol and 43.5% water) manufactured by Hospira
was purchased fromWestern Medical Supply (Arcata, CA).
2.2. Animal subjects
The animals were maintained in facilities fully accredited by the As-
sociation for Assessment and Accreditation of Laboratory Animal Care,
and all experiments involving the animals were approved by the Insti-
tutional Care and Use Committee at University of California Davis.
Naïve male NIH Swiss mice (6 weeks of age) were purchased from the
National Cancer Institute (Bethesda, MD). Upon arrival, the mice were
housed 4 per cage in clear polycarbonate cages with corncob bedding.
A paper ﬁber nestlet (Ancare, Waupaca, WI) and shredded paper were
added to each cage as enrichment. The subjects were housed on a
12 h light/dark cycle, lights on at 7 AM, in a vivarium maintained at
20–22 °C and ~45% humidity. Mice received unlimited access to chow
andwater, andwere acclimated to housing conditions for 7 d before be-
ginning any experiments. Separate cohorts of mice were used to assess
behavioral and/or cognitive deﬁcits at 1 week, 1 month and 2 months
post-vehicle (VEH) or post-TETS administration (Fig. 1). VEH and TETS
mice from the 1 week cohort were assessed for post-treatment weight
loss before beginning behavior assessments. Both VEH and TETS mice
gained weight at a similar rate, approximately 2 g over 1 week. Since
body weight increases were similar at 1 week post-treatment, weights
were not tracked at 1 and 2 months post-treatment.
2.3. Dosing paradigm
On the day the animals were exposed to TETS, stock solutions of
TETS were sequentially diluted in warm saline to a ﬁnal concentration
of 0.015 mg/ml in 10% DMSO and administered by intraperitoneal (ip)
injection in a volume of 10 ml/kg. Immediately after dosing, the animals
were observed for up to 60 min for behavioral evidence of seizures.
Time to seizure onset and duration of each seizure were recorded for
each animal. Diazepam (5 mg/kg in 10% DMSO in saline ip in a total
volume of 5 ml/kg) was administered following the second clonic
seizure, approximately 20min post-TETS injection (Fig. 1). Vehicle con-
trol animals (VEH) were injected with the vehicle used for TETS (10%
DMSO in saline ip) at 10 ml/kg followed 20 min later with diazepam
(5 mg/kg ip in a total volume of 5 ml/kg).
2.4. Behavioral tasks
To minimize carryover effects, behavioral tasks were performed in
the order of least stressful to most stressful in all three cohorts
(Fig. 1B–D). All behavioral tasks were performed between 9:00 and
16:00 (7 h) with a minimum of 24 h between tasks. A trained observer
blind to experimental treatment groups ran all the behavioral tasks.
2.4.1. Test validation
Initially, a cohort of naïve NIH Swissmicewas run through all behav-
ioral tasks to assure that these animals were capable of performing a
given task and that their performance had the capacity to be altered
by TETS treatment (Table 1). Interestingly, during this validation testing,
we discovered that adult NIH Swiss mice exhibited low freezing scores
and minimal reactivity following the tone–shock pairings in the fear
conditioning assay (see Supplementary data, Supplementary Fig. 1).
Therefore, this test was not included in the behavioral battery conduct-
ed with the TETS intoxicated animals.
Fig. 1. Exposure and testing paradigms. (A) TETS exposure paradigm. Mice injected with TETS at 0.15 mg/kg exhibit a characteristic pattern of convulsive behavior consisting of 2 brief
periods of clonic seizureswithin 20min. Lethality is prevented in 75% of the animals by administering diazepam (5 mg/kg, ip) immediately after the second clonic seizure. Onset to clonic
seizures (average), seizure length (mean ± S.D.) and percent lethality were determined by combining data from all three experimental cohorts. Separate cohorts of mice were used to
assess behavior at varying times post-TETS or VEH exposure: (B) 1 week (n = 11 VEH, 12 TETS), (C) 1 month (n = 18 VEH, 17 TETS) and (D) 2 months (n = 15 VEH, 11 TETS).
Abbreviations: EPM, elevated plus-maze; Tail Sus., tail suspension; NOR, novel object recognition.
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The elevated-plus maze (EPM) is a well-established task for
assessing anxiety-like conﬂict behavior in rodents by allowing mice to
choose between entering the two open arms of the maze (natural ex-
ploratory drive) or entering and remaining in the safety of the two
closed arms. All four arms are elevated 1 m from the ﬂoor, with the
drop-off detectable only in the open arms (Hogg, 1996). The EPM was
performed according to previously described procedures (Bailey et al.,
2007; Silverman et al., 2011) using a mouse EPM (model ENV-560A)
purchased from Med Associates (St. Albans, VT). The EPM contained
two open arms (35.5 cm × 6 cm) and two closed arms (35.5 cm
× 6 cm) radiating from a central area (6 cm × 6 cm). A 0.5 cm high lip
surrounded the edges of the open arms, whereas the closed arms
were surrounded by 20 cm high walls. The EPM was cleaned with 70%
ethanol before the beginning of the ﬁrst test session and after each sub-
jectmousewas tested, with sufﬁcient time for the ethanol odor to dissi-
pate before the start of the next test session. Room illumination was
~30 lx. To begin the test, themousewas placed in the central area facing
the open arm. Themousewas allowed to freely explore for 5min during
which time the activity was recorded by closed circuit television
(CCTV). A trained investigator validated the output of the Med Associ-
ates software according to previously published methods (File et al.,
2004; Walf and Frye, 2007).Table 1
Task validation in naïve NIH Swiss mice.
Task validation Mean ± SD N
Anxiety-like behavior
Elevated-plus maze
% time in open arm 42 ± 6.04 9
Open entries 16 ± 3.6 9
Total entries 27 ± 4.6 9
Light↔ dark exploration
Time in dark (s) 310 ± 92 9
Total transitions 51 ± 16 9
Depression-relevant behavior
Tail suspension
% time immobile 41 ± 18 9
Forced swim
% time immobile 13 ± 8.9 9
Naïve NIH Swiss mice were evaluated on each behavioral task to conﬁrm that NIH Swiss
mice responded to each task as predicted from the literature: EPM (Lister, 1987);
light↔ dark (Holmes et al., 2001; Kulesskaya and Voikar, 2014; Silverman et al., 2010);
tail suspension (Cryan et al., 2005); forced swim (Can et al., 2011; Lucki et al., 2001).2.4.3. Light↔ dark transitions
The light↔ dark transitions test (Crawley and Goodwin, 1980), also
termed the light/dark box, assesses anxiety-like conﬂict behavior in
mice by evaluating the tendency of mice to avoid brightly lit areas
versus their strong tendency to explore a novel environment. The
light↔ dark transitions test was performed in accordance with previ-
ously described procedures (Brielmaier et al., 2012; Silverman et al.,
2011). The test began by placing the mouse in the light side (~320 lx;
28 cm × 27.5 cm × 27 cm) of an automated 2-chambered apparatus,
in which the enclosed/dark side (~5 lx; 28 cm × 27.5 cm × 19 cm)
was reached by traversing the small opening of the partition between
the two chambers. The mouse was allowed to explore freely for
10 min. Time in the dark side chamber and total number of transitions
between the light and dark side chambers were automatically recorded
during the 10 minute session using Labview 8.5.1 software (National
Instruments, Austin, TX).
2.4.4. Open ﬁeld
General exploratory locomotion was assessed using the novel open
ﬁeld test as previously described (Silverman et al., 2011; Yang et al.,
2012). Brieﬂy, a mouse was placed into a novel open ﬁeld arena
composed of plexiglass and measuring 42 cm long by 42 cm wide by
31 cm high. The open ﬁeld arena was interfaced with VersaMax detec-
tion software (AccuScan, Omni-Tech Electronics, Columbus, OH) to de-
tect photobeam breaks. Locomotor activity was monitored for 30 min
using photocell detectors. Total distance, center time, horizontal and
vertical activities were automatically recorded with VersaMax 400 soft-
ware (AccuScan).
2.4.5. Tail suspension
The tail suspension test is a model of “behavioral despair” that was
designed to assess antidepressant drug effects. When suspended by
the tail, mice actively struggle to escape, then dangle immobile (Steru
et al., 1985). Antidepressants decrease time immobile in this test,
hence its use to assess depression-relevant behavior (Cryan and
Holmes, 2005; Steru et al., 1985). Here, we measured depression-
relevant behavior using an automated tail suspension test for mice
(MED-TSS-MS, Med Associates). The mouse was attached by the distal
end of its tail to a metal hanger using medical tape. The metal hanger
transmits movement of the mouse to a load cell (gain = 16; thresh-
old = 10–60), which then transmits this signal to the interfaced com-
puter. Movement data collected for a total of 6 min (resolution =
200 ms) were analyzed using Tail Suspension Software (Med Associ-
ates) and used to calculate the percent time immobile.
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The forced swim taskmeasures antidepressant drug response on an-
other measure of “behavioral despair.” When placed in a cylinder of
water too deep to escape, mice will ﬁrst swim, then stop swimming
and ﬂoat. Amount of time themouse ﬂoats, i.e. gives up trying to escape
from a tank ofwater, is calculated as the percent time immobile (Porsolt
et al., 1977). A clear Plexiglas cylinder 20 cm in diameter was ﬁlled with
water (24 ± 1 °C) to a depth of 15 cm. A mouse was placed in the
cylinder for a 6 min swim session. Behavior was recorded using a
CCTV camera. A trained observer blind to treatment later scored the
last 4 min (broken into 5 s intervals) of each swim session for immobil-
ity (lack ofmovement except those necessary to keep themouse aﬂoat).
Data are presented as the percent time immobile.
2.4.7. Novel object recognition
The novel object recognition (NOR) task was used to assess recogni-
tionmemory (Bevins and Besheer, 2006) in VEH and TETS-treatedmice.
This task was selected after we discovered that NIH Swiss mice appear
to be insensitive to fear conditioning (Supplementary Fig. 1). NOR was
performed over two days as previously described (Brielmaier et al.,
2012; Yang et al., 2012). On the ﬁrst day, the mouse was allowed to ha-
bituate to the open ﬁeld arena by freely exploring for 30min. After 24 h,
the mouse was placed back into the same open ﬁeld arena for a 10 min
habituation session. The subjects were then removed from the area and
placed in a holding cagewhile two identical objectswere placed into the
open ﬁeld area (~2 min). The subject was placed back into the arena for
a 10 min familiarization session during which time spent snifﬁng each
object was recorded. Next, the mouse was removed from the area and
placed back in its holding cage during which time the objects were
cleaned. After 60 min, the mouse was placed back into the arena with
one familiar object and one novel object. During this recognition
phase of the test, the animal was allowed to freely explore both objects
for 5minwhile snifﬁngbehaviorwas recorded. Objectswere small plas-
tic toys of different shapes and colors matched for size and reﬂective
properties. One object was a light brown treasure chest and the second
object was a light orange coral. Familiar and novel objects were
counterbalanced among test subjects. A trained observer scored videos
of the familiarization and recognition sessions for time spent investigat-
ing each object. Object investigation was deﬁned as amount of time
spent snifﬁng the object when the nose was deliberately pointed to-
ward the object at less than 2 cmdistance. Recognitionmemorywas de-
ﬁned as signiﬁcantly more time spent snifﬁng the novel object than the
familiar one during the recognition session. Time spent snifﬁng the right
and the left objects during the familiarization phase conﬁrmed no in-
nate object preference.
2.5. Statistics
For anxiety-like and depression relevant behaviors, a Student's t-test
was used for comparisons between VEH and TETS groups. When
normality failed, a Mann–Whitney U test was utilized to identify signif-
icant differences between treatment groups. For locomotor activity,
data from each 30 min session time was totaled and VEH versus TETS
groups compared using a Student's t-test. A two-way ANOVA was
utilized to determine statistical signiﬁcance when comparing two
factors (treatment, object) during NOR. For all behavioral tasks, mice
performing outside two standard deviations from the mean within a
speciﬁc treatment group were considered statistical outliers and the
data point was excluded from analysis for that given behavioral task.
For the 1 week EPM measurement, video recording failed for 4 VEH
mice and, therefore, these mice could not be scored. Also for this task
and time point, 2 TETS treated mice were identiﬁed as outliers and
were excluded from analysis. Video recording failure during 1 week
NOR familiarization phase resulted in 2 fewer VEH animals and 1 less
TETS animal out of 15 animals. For the 1 month measurement, 2 TETS
treated mice were identiﬁed as outliers and excluded from the EPManalysis. Also at this time point, 3 TETS mice were excluded from tail
suspension due to the mice escaping from the task and 3 TETS mice
were excluded from the light↔ dark transitions test due to an unex-
pected loud noise during testing. At the two month time point, no
data was excluded from analysis for any reason. Data are presented as
themean± standard deviation (SD). For theANOVA and t-test compar-
isons the F and t statistics, respectively, are listed with the degrees of
freedom in parentheses.
3. Results
3.1. Cohort survival and seizure characteristics in TETS treated mice
Consistent with previous observations (Zolkowska et al., 2012), the
mice dosed with TETS at 0.15 mg/kg ip displayed a brief period of hy-
peractivity followed by a period of somnolence, Straub tail, twitches,
imbalance followed by a stereotypic pattern of seizure activity
consisting of two brief periods of clonic seizures followed by tonic
seizures and death (Fig. 1A). Administration of diazepam (5 mg/kg,
ip) following the second period of clonic seizures prevented the lethal
tonic seizures (Fig. 1A). Three separate cohorts of TETS-intoxicated
mice rescued by diazepam and their vehicle controls were employed
to test behavior at three different post-exposure time points
(Fig. 1B–D). Overall, the seizure duration during the two clonic
seizures was similar across the three separate cohorts of mice. In the
1 week cohort, the ﬁrst clonic seizure lasted for an average of 21 s and
the second clonic seizure, an average of 35 s. In the 1 month and
2 month cohorts, the duration of the ﬁrst clonic seizure averaged 25
and 24 s, respectively, while the duration of the second clonic seizure
averaged 37 and 35 s, respectively.
The survival rate was less consistent than the clonic seizure length
across cohorts. In the 1 week cohort, 11 of 18 mice (61%) survived
acute TETS intoxication at 24 h; in the 1 month cohort, 17 of 18 mice
(94%) survived; in the 2 month cohort, 11 of 16 mice (69%) survived.
Average 24 h survival after acute TETS exposure was 75% (39/52) across
all three cohorts. The 24 h survival rate of mice administered VEH was
100%.
3.2. Acute TETS intoxication alters locomotor activity in mice
At 1 week post-TETS intoxication (cohort 1), TETS intoxicated mice
exhibited novel open ﬁeld exploratory locomotion that was not signiﬁ-
cantly different from that of VEH controlmice as indicated by horizontal
activity (t(21)= 0.924), vertical activity (t(21)= 0.195), total distance
(t(21)= 0.286) and center time (t(21)= 0.966) (Fig. 2A). At 2 months
post-intoxication (cohort 3, Fig. 2B), TETS treatedmice displayed signif-
icantly greater horizontal activity (t(24) = 0.0196) and total distance
(t(24) = 0.0235) relative to VEH control mice, suggesting slight hyper-
activity. There were no signiﬁcant differences, however, between VEH
and TETS treated mice at 2 months post-exposure for vertical activity
(t(24) = 0.286) and center time (t(24) = 0.795) (Fig. 2B).
3.3. Mice intoxicated with TETS do not exhibit anxiety-like and
depression-relevant behaviors
To determine whether acute TETS intoxication altered anxiety-like
behavior, we employed the EPM and light↔ dark transitions tests in
three separate cohorts of mice evaluated at 1 week, 1 month or
2 months post-exposure. At 1 week post-TETS intoxication, there
were no signiﬁcant differences between VEH and TETS treated mice in
the EPM with respect to the percent time spent in open arms
(t(15) = 0.279) (Fig. 3A) and total arm entries (t(15) = 0.281)
(Fig. 3B). Mice administered TETS showed a trend toward higher open
arm entries compared to VEH treated mice (t(15) = 0.0648) (Fig. 3C).
In the light↔ dark transitions test, at 1 week post-exposure, VEH and
Fig. 2. VEH and TETS treatedmice exhibited similar open ﬁeld activity. Mice injected with TETS or VEHwere assessed for open ﬁeld activity approximately 1 week (A) and 2 months post-exposure (B). Locomotor activity was determined in an open
ﬁeld arenausing total distance traveled, horizontal activity, vertical activity and center time and as standard endpoint parameters. The left graph describes each parameter over 5min time intervals, while the right graph describes total activity over the
30min testing period. In Figs. 2–5, data are presented as the mean± SD, and the number of mice tested per treatment group appears within the graphs below the respective data. *Indicates statistically signiﬁcant differences between VEH and TETS
treatment groups using Student's t-test (p b 0.05).
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Fig. 3. TETS treated mice did not exhibit anxiety-like behavior. Mice intoxicated with TETS and VEH controls were assessed on two standard anxiety-like assays at 1 week, 1 month and
2 months post-exposure. Endpoints assessed in the elevated plus maze (EPM) included the following: (A) percent time in open arm; (B) open arm entries; and (C) total arm entries.
Endpoints assessed in the light↔ dark transitions test included (D) time spent in the dark chamber and (E) total number of transitions between the light and dark chambers [*Indicates
a statistically signiﬁcant difference between VEH and TETS mice as determined by Student's t-test (p b 0.05).]
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and total transitions (t(21) = 0.909) (Fig. 3D and E).
At 1 month post-TETS intoxication, no signiﬁcant differences were
detected between VEH and TETS treated mice in the EPM for open
arm entries (t(32) = 0.121) and total arm entries (t(32) = 0.920)
(Fig. 3B and C). In this cohort, however, TETS treated mice spent signif-
icantly more time in the open arms as compared to VEH treated mice
(t(32) = 0.00624) (Fig. 3A). In the light↔ dark transitions test at
1 month post-exposure, there were no signiﬁcant differences between
VEH and TETS treatedmicewith respect to time spent in the dark cham-
ber (t(31) = 0.689) (Fig. 3D) or total transitions between the light and
dark chambers (t(31) = 0.457) (Fig. 3E).
At 2 months post-treatment, the percent time in open arms and
open arm entries in the EPM were not signiﬁcantly different between
TETS-treated and VEH control mice (Fig. 3A and B). In this cohort, the
TETS treated mice showed a trend toward more total arm entries than
VEH treated mice (t(24) = 0.0530) (Fig. 3C). In the light ↔ dark
transition test, TETS intoxicated mice exhibited time in dark (t(24) =
0.220) (Fig. 3D) and total transition (t(24) = 0.214) (Fig. 3E) values
that were not signiﬁcantly different from VEH control mice.
To assess depression-relevant behavior in mice intoxicated with
TETS, we employed the tail suspension and Porsolt forced swim tests.
During the tail suspension test, immobility was not signiﬁcantly
different between TETS intoxicated mice and VEH control mice at the
1 week (t(21) = 0.468), 1 month (t(31) = 0.988) or 2 month(t(24)= 0.200) timepoints (Fig. 4A). Similarly, thepercent time immo-
bile in the forced swim testwas not signiﬁcantly different between TETS
intoxicated and VEH control mice at 1 week (t(21) = 0.708), 1 month
(t(31) = 0.282) and 2 months (t(24) = 0.504) post-exposure (Fig. 4B).
3.4. Acute TETS intoxication does not impair recognition memory
To assess the effects of acute TETS intoxication on memory, we ini-
tially planned to use contextual fear conditioning. However, our initial
validation of these tests with the adult male NIH Swissmouse indicated
that this strain did not display the standard immobility or freezing re-
sponse after fear conditioning. Using the same standard conditioning
procedures, age- and sex-matched C57BL/6J mice exhibited normal
freezing responses during the contextual and cued phases, demonstrat-
ing the expected learning and memory in this task (Supplementary
Fig. 1). Our ﬁnding is similar to that of Clapcote and colleagues who
demonstrated that NIH Swiss mice were insensitive to contextual fear
conditioning (Clapcote et al., 2005b). Since fear conditioning employs
mild foot shocks, a possible explanation is that NIH Swiss mice are less
sensitive to the aversive foot shock and therefore did not learn the
negative association that subsequently caused freezing. To test this hy-
pothesis, we employed two standard pain sensitivity tasks for mice, hot
plate and tail ﬂick nociception. Relative to C57BL/6J mice, the NIH Swiss
mice exhibited signiﬁcantly decreased pain sensitivity (Supplementary
Fig. 2), which may explain the poor response of the NIH Swiss mice in
Fig. 4. VEH and TETS treated mice exhibited similar depression-related behavior.
TETS-intoxicated mice and VEH control mice were assessed for depression-relevant be-
havior at 1 week, 1 month and 2 months post-injection. Depression-relevant behavior
was determined using (A) tail suspension and (B) forced swim, with percent time immo-
bile as the endpoint measured in both tasks. No statistically signiﬁcant differences were
detected between VEH and TETS treatment groups using Student's t-test (p b 0.05).
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learning andmemory task to determinewhether acute TETS intoxication
impairs memory in NIH Swiss mice, novel object recognition (NOR).
At the 1week post-treatment time point, both VEH and TETS treated
mice recognized the familiar object and spent signiﬁcantly more time
snifﬁng the novel object (F(1,24) = 38.6, p b 0.001) (Fig. 5A). Normal
NOR scores were similarly obtained at 2 months post-treatment
(F(1,23) = 48.8, p b 0.001) (Fig. 5B). During the familiarization phase,
at 1 week (Fig. 5A) and 2 months (Fig. 5B) post-exposure, neither
TETS intoxicated mice nor VEH control mice displayed a preference for
object position during the familiarization phase (1 week: F(1,21) =
0.227, p= 0.636; 2 months: F(1,23)= 0.322, p= 0.858). On the control
measure of location of objectswithin the open ﬁeld, therewas no signif-
icant difference between treatment groups for time snifﬁng left and
right object at 1 week (F(1,21) = 0.0438, p = 0.835) or at 2 months
(F(1,23) = 0.111, p = 0.740) (Fig. 5A and B). On the control measure
of total sniff time, there was no signiﬁcant difference between treat-
ment groups at either time point for total time spent snifﬁng the famil-
iar versus novel objects (1 week: F(1,24) = 0.102, p= 0.752; 2 months:
F(1,23) = 0.552, p = 0.465) (Fig. 5).
4. Discussion
Clinical case reports indicate that individuals who survive
TETS-induced seizures may experience anxiety, depression and/or
memory impairments that persist for months to years following expo-
sure (Bai et al., 2005; Whitlow et al., 2005; Zhang et al., 2011). Thus,
the major goal of this study was to determine whether TETS-induced
seizures cause short- and/or long-term effects on anxiety-like,
depression-relevant and/or cognitive behavior in a recentlycharacterized “TETS rescue” mouse model. Previous characterization
of this model demonstrated that administration of TETS at 0.15 mg/kg
(ip) to adult male NIH Swiss mice causes clonic–tonic seizures that
are typically lethal within 25–30 min post-exposure (Zolkowska et al.,
2012). However, administration of a high dose of diazepam following
the second clonic seizure but before the onset of tonic seizures rescues
these TETS intoxicated mice from death and from further seizures, as
determined both behaviorally and electroencephalographically (Vito
et al., in press). The results of this study are consistentwith the previous
studies, as all TETS intoxicated mice used for the behavioral studies
described herein were documented to undergo two clonic seizures.
The major ﬁndings of the behavioral studies were that relative to VEH
control mice, TETS intoxicated mice: (1) did not exhibit signiﬁcant
anxiety-like or depression-relevant behaviors or cognitive impairment
at 1 week, 1 month or 2 months post-exposure; and (2) displayed
increased locomotor activity at 2 months but not at 1 week post-
exposure in the novel open ﬁeld arena.
Anxiety-like behavior was assessed using two standard corrobora-
tive assays, elevated plus-maze and light↔ dark transitions (Crawley,
2007, 2008). Our pre-experimentation validation study had indicated
that naïve adult male NIH Swiss mice perform as expected in these
tests. On almost all parameters, scores were similar in the TETS and
vehicle treatment groups. While we did observe that relative to VEH
control mice, TETS intoxicated mice demonstrated trends on one
parameter, increased open arm entries, at 1 week post-exposure, and
on another parameter, more total arm entries, at two months post-
exposure in the EPM, these trends were not signiﬁcant. Further, no
treatment trends were seen in the light↔ dark transitions test. The
lack of robust difference in the time spent in the closed arms and the
open arms during EPMmight be due to visual deﬁcits caused by the ret-
inal degeneration gene in the background of NIH Swiss mice, since
Clapcote and coworkers reported impaired performance by NIH Swiss
mice in the Morris water maze, which relies of distal visual cues
(Clapcote et al., 2005b). However, it is known that other senses includ-
ing tactile and olfactory abilities are used when the mouse explores the
open arms. Consistent with this observation, Milner and Crabbe have
shown that visual impairment does not adversely affect the scores on
conﬂict anxiety tasks like the elevated-plus maze (Milner and Crabbe,
2008). Fear conditioning similarly employs visual cues, but these are ac-
companied by tactile cues from the composition of the ﬂoor and shape
of the chamber, along with applied olfactory stimuli and the auditory
tone. These other sensory modalities represent strong stimuli for mice,
leading to our interpretation that differential pain sensitivity is the
more likely interpretation of the reduced response of NIH Swiss mice
to footshock-induced training on the fear conditioning task. In support
of this interpretation, Clapcote and colleagues concluded that the pres-
ence of the rd1 mutation, which causes retinal degeneration, had no ef-
fect on performance in the fear conditioning procedure (Clapcote et al.,
2005a) and a recent paper by Iura and Udo (2014) reported normal fear
conditioning in blind mice.
Depression-relevant behavior was assessed using two standard cor-
roborative assays, forced swim and tail suspension.We observed no sig-
niﬁcant differences between TETS intoxicated mice and VEH controls in
the either assay at any post-treatment time point. The small increase in
open ﬁeld exploratory activity was detected at only one time point,
1 month post-treatment, and on only two of the four open ﬁeld param-
eters. Cognition was assessed using novel object recognition, a widely
used test to assess recognition memory of same versus different objects
inmice (Bevins and Besheer, 2006; Crawley, 2008; Dere et al., 2007). No
signiﬁcant differences between treatment groups were detected on this
learning andmemory task. Thus, in this speciﬁc mousemodel, acute in-
toxicationwith TETS at levels that cause seizures, as documented by im-
mediate seizure behaviors and EEG recordings in a separate cohort of
NIH Swiss mice (Vito et al., in press), there is no evidence of long-
term changes in anxiety-like behavior, depression-relevant behavior,
exploratory behavior or impaired cognitive behavior.
Fig. 5. Acute TETS intoxication did not impair recognition memory. Recognition memory was assessed in TETS intoxicated mice and vehicle control mice using novel object recognition
(NOR). NOR was assessed in the same cohort of animals at (A) 1 week and (B) 2 months post-exposure. During the familiarization phase, object place preference was evaluated using
total snifﬁng time of the right versus left object. During the testing phase, novel object recognition was assessed using total snifﬁng time of the novel versus familiar objects. During
both phases, object locations within the arena were counterbalanced. *Indicates a statistically signiﬁcant difference between familiar and novel object within each treatment using a
Student's t-test (p b 0.05). No statistically signiﬁcant treatment-related differences were identiﬁed using two-way ANOVA (p b 0.05).
43B.M. Flannery et al. / Neurotoxicology and Teratology 47 (2015) 36–45Ourdata suggest that the long-termbehavioral and cognitive deﬁcits
reported in clinical case studies of patients who survive TETS-induced
seizures (Bai et al., 2005;Whitlow et al., 2005; Zhang et al., 2011) either
reﬂect species-dependent differences in response to acute TETS intoxi-
cation or, more likely, result from SE-induced brain damage than from
a direct effect of TETS itself. Rodent and human models demonstrate
that SE induces neuronal damage in areas critical for behavior, learning
and memory (Sheppard and Lippe, 2012). Histological analyses of
brains frompatients who died 11–27 d after theﬁrst episode of SE dem-
onstrated extensive neuronal damage in the hippocampus, entorhinal
cortex, amygdala and dorsomedial thalamic nucleus (Fujikawa et al.,
2000). Additionally, baboons showed neuronal damage in the neocor-
tex, thalamus and hippocampus after SE induced by bicuculline
(Meldrum et al., 1973). While the deﬁnition of SE may vary between
studies, many population-based studies deﬁne SE as a continuous
state of seizing for 5–30 min or longer (Trinka et al., 2012). In humans,
the occurrence and severity of SE-induced neurological sequelae, such
as developmental delay, hyperactivity and mental retardation, are
closely associated with the duration of SE (Eriksson and Koivikko,
1997). Similarly, in rat models of bicuculline-induced SE (Atillo et al.,
1983; Soderfeldt et al., 1983a,b) and SE induced by organophosphate
nerve agents (McDonough et al., 1995; Shih et al., 2003), there is a direct
correlation between the extent and severity of neuronal damage and
the duration of seizures. Thus, the most plausible explanation for why
the performance of NIH Swiss mice in our behavioral tests was not im-
paired by TETS is that the seizures experienced by these mice were not of
sufﬁcient duration to cause neuronal damage. In ourmodel, TETS intoxicat-
ed mice experienced clonic seizures that lasted 72 s on average, and as wepreviously reported, these seizures are not associated with overt neuronal
injury or cell death as determined by hematoxylin and eosin stain and
FluoroJade B labeling (Vito et al., in press; Zolkowska et al., 2012).
While we have not observed overt neuronal injury in the brains
of mice that have experienced TETS-induced seizures, we have consis-
tently observed delayed neuro-inﬂammation, evident as reactive
astrogliosis and microglial activation (Vito et al., in press; Zolkowska
et al., 2012). Behavioral deﬁcits and cognitive decline are associated
with neuroinﬂammation (Corona et al., 2012; Dantzer et al., 2008;
Maes et al., 2009; Smith, 2013), andwith neuroinﬂammatory conditions
such as Alzheimer's disease and aging (Eikelenboom et al., 2002;
Gimeno et al., 2009; Kuo et al., 2005; Piazza and Lynch, 2009). Neuroin-
ﬂammation is characterized by increases in glia in the brain, particularly
astrocytes and activated microglia that release inﬂammatory cytokines
such as interleukins and chemokines. Both clinical human data and an-
imal seizure models report neuroinﬂammation following SE (Drexel
et al., 2012; Fujikawa et al., 2000; Liu et al., 2012; Steward, 1994). In
these models, neuroinﬂammation is thought to result from neuronal
damage; however, intrahippocampal administration of interleukin-1β
(IL-1β) impairs contextual fear conditioning in rats (Hein et al., 2007),
and, increases in hippocampal IL-1α, IL-18 and interferon-γ are associ-
atedwith decreases in long-term potentiation (Grifﬁn et al., 2006). Col-
lectively, these data would suggest that the TETS-induced
neuroinﬂammation observed in our TETS rescue mouse model is not
sufﬁcient to impair performance in the anxiety-like, depression-
relevant and cognitive tests employed in this study. Further, it raises
the question of whether neuroinﬂammation is an essential component
of post-SE brain injury.
44 B.M. Flannery et al. / Neurotoxicology and Teratology 47 (2015) 36–45To summarize, acute TETS administration did not impair perfor-
mance of adult male NIH Swiss mice in a battery of tests to assess anx-
iety, depression and cognition, likely due to short duration of seizure
activity and the lack of neuronal lesions and neurodegeneration. These
important negativeﬁndings could indicate that emotional and cognitive
disruptions in humans exposed to TETS are due to non-biological
causes, and/or that the dosing regimen used in this study did not sufﬁ-
ciently recapitulate the severity of seizures and brain damage experi-
enced in humans exposed to TETS. Future studies will focus on
developing mouse models that more precisely match the degree of
TETS-induced SE observed in humans.
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Supplementary Figure 1. NIH Swiss mice do not respond in fear conditioning task. Naïve NIH 
Swiss and C57BL/6J (B6) mice were subjected to fear conditioning. (A) Time spent freezing prior to 
conditioning (pre-condit) and following (post-condit) 3 tone-shock (CS-UCS) pairings.  (B) The context 
test was performed 24 h after conditioning and (C) the cue test, 24 h after the context test. Data are 
presented as the mean ± SD. **For the context test, asterisks indicate a statistically significant 
difference between strains as determined using the Student’s t-test (p < 0.01). For conditioning and cue 
tests, data were compared using repeated measures two-way ANOVA with a Tukey’s post-hoc test. 
Different letters indicate a statistically significant difference between PRE and POST within a mouse 
strain (p < 0.05). Asterisks indicate a statistically significant difference between mouse strains within 
PRE or POST (p < 0.01). 
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Supplementary Figure 2. NIH Swiss mice exhibit decreased pain sensitivity compared to B6 
mice.  To assess nociception, naïve mice were subjected to the hot plate and tail flick tests.  Data are 
presented as the mean ± SD. **Indicates a statistically significant difference between strains as 
determined using the Student’s t-test (p < 0.01). 
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Supplementary Methods. 
Mice. All experiments involving animals were approved by the Institutional Care and Use Committee at 
University of California Davis. Naïve NIH Swiss male mice (6 weeks of age) were purchased from the 
National Cancer Institute (Bethesda, MD); naïve male C57BL/6J mice (6 weeks of age) were purchased 
from Jackson Labs (Sacramento, CA). Upon arrival, mice were housed 4 per cage in clear 
polycarbonate cages with corn cob bedding. A nestlet and shredded paper were added to each cage as 
enrichment. Subjects were housed on a 12 h light/dark cycle at 20 - 22⁰C and ~45% humidity. Mice 
received unlimited access to chow and water, and were acclimated to housing conditions for 7 d before 
beginning any experiments.  
 
Fear Conditioning. Fear conditioning was used to assess learning and memory in mice and was 
performed as previously described (Bainbridge, Koselke et al. 2008; Brielmaier, Matteson et al. 2012). 
During fear conditioning, mice learn to associate the context of the chamber and the white noise cue 
with a foot shock.  If they remember the association, mice will exhibit freezing behavior when 
challenged again with the context or cue.  Freezing behavior is defined as a lack of movement other 
than breathing. Mice were placed in a chamber with a metal floor grid (Med Associates, St. Albans, VT) 
containing vanilla scent (McCormick, Hunt Valley, MD) diluted 1:100 in phosphate-buffered saline 
(PBS) and with house lights on. After 2 min, mice were subjected to the conditioned stimulus (CS), a 
white noise cue, for 30 sec followed immediately by a 2.5 sec foot shock (unconditioned stimulus, US) 
of 0.5 mA. This sequence was repeated two more times with 90 sec inter-shock intervals. After the last 
CS-US pairing, the mouse remained in the chamber for 150 sec with no noise or shock. Chambers 
were cleaned thoroughly with 70% ethanol between subjects. Memory was tested to the context at 24 
hours and to the auditory cue at 48 h after conditioning, respectively. For the context test, mice were 
placed back in the vanilla scented chamber for 300 sec. For the cue test, the chamber floor was 
changed to smooth plastic, the house lights turned off, the scent cue changed to lemon (McCormick) 
diluted 1:100 in PBS, and a black triangular inset was placed in the chamber. Mice were placed in the 
silent chamber for 180 sec followed by the white noise cue for 180 sec and ending with a 90 sec period 
of silence. All trials of fear conditioning were recorded using an Ikegami infrared camera (V and H 
Photo, New York, New York). Freezing was scored using Video Freeze software (Version 1.12.0.0, Med 
Associates).  
 
Hot plate and tail flick nociception tests. Thermal stimulation was applied to either the feet or the tail of 
mice to determine their response. Hot plate and tail flick tests were performed as previously described 
(Silverman, Yang et al. 2010). In the hot plate test, mice were placed on a 55⁰C surface (IITC Life 
Science, Woodland Hills, CA). Latency until their first response to the hot plate, such as vocalization, 
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shaking or licking paws, was recorded by an observer with a stopwatch. In the tail flick test, mice were 
gently restrained and their tail tip placed in the tail-flick groove of the tail flick monitor (Columbus 
Instruments, Columbus, OH). A photo beam that applied thermal stimulation was applied to the tail and 
the time until the mouse moved its tail out of the photo beam path.  Latency to move the tail was 
recorded by an observer with a stopwatch.  
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